Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:nintedanib
|
| gptkbp:approvalYear |
2014
|
| gptkbp:ATCCode |
L01XE31
|
| gptkbp:CASNumber |
656247-17-5
|
| gptkbp:chemicalFormula |
C31H33N5O4
|
| gptkbp:drugClass |
antifibrotic agent
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ofev
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Boehringer_Ingelheim
|
| gptkbp:mechanismOfAction |
gptkb:receptor_tyrosine_kinase
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting diarrhea liver enzyme elevation |
| gptkbp:tradeNameOf |
gptkb:nintedanib
|
| gptkbp:usedFor |
idiopathic pulmonary fibrosis
systemic sclerosis-associated interstitial lung disease chronic fibrosing interstitial lung diseases with a progressive phenotype |
| gptkbp:bfsParent |
gptkb:Boehringer_Ingelheim
|
| gptkbp:bfsLayer |
6
|